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During a 34-month period (January 1991 to October 1993), 31 Corynebacterium striatum strains recovered
from clinical samples from 24 patients were characterized. Twenty (64%) strains were isolated from wound
exudates, 5 (16%) were isolated from bronchial aspirates, 2 (7%) were isolated from urine, 2 (7%) were isolated
from endotracheal tubes, 1 (3%) was isolated from a catheter, and 1 (3%) was isolated from empyema. The
organisms were identified by conventional culture and phenotypic characterization, the API CORYNE system,
and cellular fatty acid composition analyses. The colonies of C. striatum could be confused with those of
coagulase-negative staphylococci upon primary isolation from clinical material. A consistent phenotypic
pattern was observed: all strains reduced nitrate, hydrolyzed tyrosine, and produced acid from glucose,
fructose, and sucrose but not from maltose. API CORYNE profile numbers were 3100105 (28 strains) and
3000105 (3 strains). Susceptibility testing of C. striatum was performed by disk diffusion. All strains were
susceptible to both imipenem and vancomycin and resistant to fosfomycin; most strains were susceptible to
ampicillin and cephalosporins and resistant to clindamycin, erythromycin, and tetracycline. Performing a
Gram stain of fosfomycin-resistant ‘‘Staphylococcus-like’’ colonies was critical in order to identify C. striatum.
Coryneform bacteria are members of the normal flora of
skin and cutaneous membranes. These organisms are being
increasingly isolated from immunocompromised hosts and pa-
tients with vascular or urinary catheters (10, 18). The impor-
tance of Corynebacterium diphtheriae declined in western coun-
tries after the introduction of an effective vaccine, but in recent
years isolation of these coryneform bacteria from patients with
infections other than classical diphtheria has been described
(10). Both Corynebacterium jeikeium and Corynebacterium
urealyticum are currently recognized as important human
pathogens (1, 3, 15, 27), but the significance or prevalence of
other Corynebacterium species as causative agents of disease is
not as well understood.
Although appreciation of the pathogenic potential of non-
diphtherial coryneform bacteria has increased, the identifica-
tion of these bacteria, including Corynebacterium striatum, con-
tinues to present difficulties for the clinical microbiology
laboratory. Definitive classification of bacteria as Corynebacte-
rium species sensu stricto necessitates the use of sophisticated
tests, such as cell wall composition analyses and nucleic acid
studies, which are often performed only at reference centers
(7, 9, 12, 17, 18). The problem is compounded by the sugges-
tion that conventional phenotypic schemes (7, 10, 16, 18) iden-
tify only about 60 to 70% of all gram-positive bacilli. There-
fore, other methods, such as cellular fatty acid (CFA)
composition analysis (5) and the API CORYNE system (13,
14, 29, 30), have been recently described to assist in the iden-
tification of coryneform bacteria.
Microbiological and clinical information specifically con-
cerning C. striatum infections is scarce. Previously, there have
been several case reports (4, 6, 8, 11, 19, 21, 23), and two series
(25, 31) have been described, whereby three and six cases,
respectively, of C. striatum infections were reported. Person-
to-person transmission of C. striatum in intensive care units has
also been described, but limited information on the clinical
charts of these patients was presented (19). In this report, we
describe the microbiological identification and susceptibility
testing of 31 C. striatum strains isolated from clinical samples
of 24 patients. Clinical information concerning these patients
will be reported separately (21a).
MATERIALS AND METHODS
Bacteria. Samples referred to the Microbiology Laboratory at the Hospital
Universitario ‘‘Virgen Macarena,’’ Seville, Spain (referred to below as HUS), in
the period from January 1991 to October 1993 were processed according to
standard methods for microbiological culture. Blood samples were processed
with the BACTEC NR860 instrument (Becton Dickinson, Paramus, N.J.). All
other samples were routinely cultured on Columbia agar base with 5% sheep
blood and, for some of them, in thioglycolate broth, as nonselective media.
Aerobic and facultative anaerobic gram-positive, pleomorphic, nonbranched,
non-spore-forming, non-acid-fast rods were included for identification to species
level. Microorganisms isolated from sterile fluids, catheters ($15 CFU by the
rolling-plate method), urine culture (#2 organisms, $104 CFU/ml), and pure or
predominant culture from wound exudates and respiratory samples were in-
cluded. C. striatum ATCC 6940 was included as a reference strain.
Conventional identification. The Centers for Disease Control (CDC) methods
and identification scheme (16) were used by the Laboratory Centre for Disease
Control (LCDC), Ottawa, Canada, for all reference and patient strains. The
phenotypic traits indicated in Table 1 were studied. Acid production from car-
bohydrates was determined by using peptone water with Andrade’s indicator and
1% carbohydrate. The CAMP test (with Staphylococcus aureus ATCC 25922 as
the marker strain), tests for production of pyrazinamidase and pyrrolidonyl
arylamidase, growth in peptone water with 0 or 0.5% Tween 80, and hydrolysis
of o-nitrophenyl-b-D-galactopyranoside (ONPG) were performed at the HUS by
standard methods. Eight randomly chosen strains were also evaluated by a slide
test (Staphylex, Oxford, United Kingdom) for production of clumping factor
and/or protein A, as usually used for Staphylococcus species.
API CORYNE. Each strain was tested at the HUS by using the API CORYNE
system (API Bio-Mérieux, Inc., La Balme Les Grottes, France) in parallel with
conventional methods described above. A 7-digit code was obtained for each
strain, and this code was interpreted by using the profile index provided by the
manufacturer (API CORYNE Analytical Profile Index [1990, 1st edition]). If
* Corresponding author. Mailing address: Dept. of Microbiology,
School of Medicine, Apdo 914, 41080 Seville, Spain. Phone:
34.5.4557448. Fax: 34.5.4377413.
2458



























supplemental tests were required, they were performed as indicated by conven-
tional methods. Growth in 6% NaCl was tested by using heart infusion broth.
CFA composition. Each strain was analyzed for CFA composition by methods
reported previously (5). Fatty acid methyl esters were analyzed by gas-liquid
chromatography with the MIDI system (Microbial Id Inc., Newark, Del.) and
Library Generation System software (MIDI) as previously described (13),
except that AEROBE version 3.7 was used as the root for the in-house method
LCDCAER2 attached to the in-house library LCDC1.
Identification of C. striatum with Pasco and MicroScan systems. As C. striatum
colonies may be confused with coagulase-negative staphylococci, eight C. stria-
tum strains were studied (at the HUS) with two semiautomated identification
systems: Pasco (Difco, Detroit, Mich.) and MicroScan (Baxter, West Sacra-
mento, Calif.). The inoculum was prepared by using the PROMPT System
(Baxter), and then the methodology recommended by the manufacturer was
followed to inoculate type 3P (Pasco) or Pos Combo 4I (MicroScan) panels.
Panels were incubated at 358C for 18 to 20 h and read with a laser pointer (Pasco)
or an automatic reader (MicroScan). In either case, the organism to be identified
was considered catalase positive. The biotype and final identification were re-
corded for further evaluation.
Antimicrobial susceptibility testing. A disk diffusion assay was used for anti-
microbial susceptibility testing. A suspension in saline equivalent to a turbidity of
0.5 of the McFarland standard was prepared by using bacteria grown on Colum-
bia agar base with 5% sheep blood at 358C for 18 to 20 h. This inoculum was
applied with a cotton swab to plates containing Mueller-Hinton agar. Disks
(Difco) of the antimicrobial agents indicated in Table 2 were applied to the
inoculated plates. Plates were incubated at 358C for 18 to 20 h. Zones of
inhibition around the disks were measured. As there are no accepted breakpoints
that specifically assign coryneform bacteria to interpretative categories, break-
points recommended by the National Committee for Clinical Laboratory Stan-
dards (24) for organisms other than Haemophilus strains and Neisseria gonor-
rhoeae have been used. For penicillin and ampicillin, breakpoints for Listeria
monocytogenes (the only gram-positive rod included by the National Committee
for Clinical Laboratory Standards) were used. Because studies of the clinical
effectiveness of vancomycin against coryneform bacteria are lacking, the break-
points for ‘‘other gram-positive’’ organisms (not for enterococci) were used.
Organisms for which inhibition zones were $15 mm were considered susceptible
to fosfomycin (2).
RESULTS
Thirty-one C. striatum isolates from 24 patients were iso-
lated: 20 (64%) from wound exudates, 5 (16%) from bronchial
aspirates, 2 (7%) from urine, 2 (7%) from endotracheal tubes,
1 (3%) from a catheter, and 1 (3%) from empyema.
All isolates grew at 37, 42, and 258C in air and 3 to 5% CO2.
Growth in thioglycolate was dense throughout the tube at 24 h.
Colonies in Columbia agar base with 5% sheep blood were
nonhemolytic; on this medium and on tryptic soy agar they
were creamy white to yellowish, with an entire edge. Growth
was not stimulated in the presence of Tween 80. A Gram stain
showed short gram-positive rods, with an occasional striped
pattern. Conventional biochemical reactions are summarized
in Table 1. As noted in Table 1, a consistent pattern was
obtained from our isolates. Three isolates were initially cate-
gorized as pyrazinamidase negative in conventional tests, but
all three were positive when the test was repeated. Eight or-
ganisms tested negative for coagulase production. All 31
strains were correctly identified as C. striatum by the API
CORYNE system. The codes obtained were 3100105 (28
strains) and 3000105 (3 strains).
All strains were observed to have CFA compositions both
qualitatively and quantitativey consistent with those described
previously for a large collection of Canadian patients and ref-
erence strains (5). A peak with an equivalent chain length of or
near 14.966, which usually failed the MIDI system’s internal
standard for maximum peak width, was observed for most
samples but not Corynebacterium xerosis, as described previ-
ously (5). Similarity index (SI) values for all strains except two
(LCDC 93-0490 [HUS 151] with an SI of 0.16 and LCDC
93-0495 [HUS 203] with an SI of 0.21) ranged from 0.50 to 0.90
relative to the LCDC1 C. striatum entry (data not shown).
The code number obtained with the Pasco system for the
TABLE 1. Conventional phenotypic traits of 31 C. striatum
isolates from clinical samples
Test of characteristic Result(% isolates with positive result)
Growth on Tinsdale agar ........................... Black, no halo
Growth on 0% NaCl................................... 1 (100)
Growth on 6% NaCl................................... 1 (100)
Catalase ........................................................ 1 (100)
Oxidase ......................................................... 2 (0)
Oxidation/fermentation of glucose............ 1/1 (100)
Triple sugar iron slant/butt ........................ Acid/acid (100)
Motility ......................................................... 2 (0)
DNase ........................................................... 2 (0)
Hydrolysis of: ..............................................
Tyrosine .................................................... 1 (100)
PYRa ......................................................... 2 (0)
Pyrazinamide............................................ 1 (100)
Esculin ...................................................... 2 (0)
Urea .......................................................... 2 (0)
Gelatin ...................................................... 2 (0)
Citrate (Simmons)....................................... 2 (0)
Nitrate reduction ......................................... 1 (100)
Indole production........................................ 2 (0)
H2S triple sugar iron butt/paper ............... 2/1 (0/100)
CAMP test ................................................... 2 (0)
Lysine decarboxylase................................... 2 (0)
Ornithine decarboxylase ............................. 2 (0)
Arginine dehydrolase .................................. 2 (0)
Acid from: ...................................................
Glucose ..................................................... 1 (100)
Ribose ....................................................... 2 (0)
Xylose ....................................................... 2 (0)
Mannitol ................................................... 2 (0)
Maltose ..................................................... 2 (0)
Fructose .................................................... 1 (100)






Starch ........................................................ 2 (0)
Trehalose.................................................. 2 (0)
a PYR, pyrrolidonyl arylamidase.
TABLE 2. Percentages of C. striatum strains isolated from clinical
samples susceptible, intermediate, and resistant to 15





Penicillin (10 U) 93 0 7
Ampicillin (10 mg) 93 0 7
Cephalothin (30 mg) 93 7 0
Cefoxitin (30 mg) 90 3 7
Cefotaxime (30 mg) 93 7 0
Imipenem (10 mg) 100 0 0
Clindamycin (2 mg) 0 3 97
Erythromycin (15 mg) 3 19 78
Ciprofloxacin (5 mg) 7 13 80
Tetracycline (30 mg) 3 0 97
Gentamicin (10 mg) 45 7 48
Amikacin (30 mg) 87 0 13
Rifampin (5 mg) 32 0 68
Fosfomycin (50 mg) 0 0 100
Vancomycin (30 mg) 100 0 0
a Abbreviations: S, susceptible; I, intermediate; R, resistant.
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eight strains tested was 010162. The corresponding identifica-
tions were as follows: Staphylococcus auricularis, 59%; Staph-
ylococcus capitis, 33%; Micrococcus spp., 8%. Similarly, when
the MicroScan system was used the code number obtained was
306000, corresponding to the following identifications: Staph-
ylococcus hominis, (63%); S. auricularis, 14%; S. capitis, 13%;
Staphylococcus epidermidis, 7%; and Staphylococcus haemolyti-
cus, 2%.
Results of antimicrobial susceptibility testing are presented
in Table 2. All strains were susceptible to both imipenem and
vancomycin, and most were susceptible to ampicillin and ceph-
alosporins. All strains were resistant to fosfomycin, and most of
them were resistant to clindamycin, erythromycin, and tetra-
cycline. Only 7 and 32% were susceptible to ciprofloxacin and
rifampin, respectively. Forty-five percent of our strains were
susceptible to gentamicin, and 87% were susceptible to ami-
kacin.
DISCUSSION
Until recently, C. striatum rarely has been reported as a
cause of human disease. The organism has been described as
causing respiratory disease (4, 6, 8, 11, 19, 23, 25), but it has
also been isolated in cases of endocarditis, septicemia, osteo-
myelitis, infections of central lines, ulcers and wounds, and eye
infections (11, 21, 31). In our hospital, C. striatum was the
coryneform bacterium most frequently isolated from clinical
samples during the period from 1990 to 1993 (21a). A signifi-
cant number of isolates in that study were obtained from re-
spiratory samples (26%), but the majority (64%) of isolates
were recovered from wound exudates and the remaining
strains were from venous catheters and urinary tracts. In a
separate study (22), we found that C. striatum was the causative
agent in a case of fatal pulmonary disease in a young, previ-
ously healthy man who was hospitalized in the intensive care
unit at HUS. Leonard et al. had also reported (19) person-to-
person transmission of a pigmented strain of C. striatum in
intensive care units.
It is clear that the recognition of C. striatum as a possible
human pathogen requires rapid and efficient methods for its
identification from clinical samples. In our experience, colo-
nies of C. striatum on blood agar media commonly used in
clinical laboratories can resemble those of Staphylococcus spp.,
as also observed by Leonard et al. (19). If a slide coagulase test
(but not a Gram stain) is performed, the organism may be
misidentified as a coagulase-negative Staphylococcus sp. The
use of commercial panels for identification of gram-positive
organisms could indeed support this misidentification. As
shown here for the eight strains tested with the Pasco and
MicroScan systems, low probability values for several staphy-
lococcus or micrococcus species should alert the clinical mi-
crobiologist to the possibility of the presence of C. striatum,
especially if the strains are also observed to be resistant to
fosfomycin. This reenforces the need for a Gram strain after
primary isolation in order to correctly and rapidly recognize
potentially pathogenic coryneform bacteria.
Final identification of a gram-positive, C. striatum-like ba-
cillus may be done on the basis of conventional or biochemical
tests and (if possible) the study of CFAs. However, Coyle et al.
(9) found that schemata to identify C. striatum phenotypically
differed, depending on whether one used the scheme described
by the CDC, based on strains with reactions similar to that of
the type strain, ATCC 6940 (16), or that described in Bergey’s
Manual of Systematic Bacteriology (7), which is based on the
1954 description of C. striatum by Munch-Petersen. Coyle and
coworkers also found in that study that three reference strains
for phenotypically similar C. xerosis were found to be geneti-
cally identifiable as C. striatum. API CORYNE identifications
are based on the CDC scheme (whereby C. striatum isolates
reduce nitrate and ferment sucrose but not maltose). In our
experience, several conventional tests may help to differentiate
C. striatum from C. xerosis. C. striatum is a short gram-positive
rod, grows as creamy, pale-yellow colonies, hydrolyzes tyrosine,
ferments sugars rapidly (24 to 36 h), and is commonly suscep-
tible to ampicillin and cephalothin, while C. xerosis is a diph-
theroid-like organism, grows as dry colonies with a sugary
texture, does not hydrolyze tyrosine, ferments sugars slowly (72
to 96 h), and is commonly resistant to ampicillin and cephalo-
thin.
In the present study (Table 1), all strains of C. striatum were
found to be consistent with the scheme as described by Hollis
and Weaver (16). All strains were identifiable by the API
CORYNE system, with only two codes being generated:
3100105 (28 strains) and 3000105 (3 strains). These identifica-
tions were considered ‘‘good to species levels’’ or ‘‘very good to
genus level,’’ with confidence levels of 97.1 and 89.1%, respec-
tively. Unlike Leonard et al. (19), who reported a positive
CAMP test for pigmented and several nonpigmented strains of
C. striatum, we did not obtain a positive CAMP reaction for
any strain. All C. striatum isolates in this study were found to
have CFA compositions consistent with that described previ-
ously (5) and demonstrated respectable similarity to the LCDC
entry for that species as first (or, in two instances, second)
choice.
Information on activities of drugs against C. striatum is also
limited. The isolates of C. striatum we tested were susceptible
to both vancomycin and imipenem and resistant to fosfomycin.
Most of the isolates were susceptible to penicillin G, ampicillin,
and cephalosporins and resistant to clindamycin, erythromycin,
and tetracycline. Roberts et al. (26) have reported that 15 of 17
strains (carrying the erm Cd gene) were resistant to clindamy-
cin and either resistant or intermediate to erythromycin and
that 13 of these strains (carrying the tetM gene) were resistant
to tetracycline. Similar rates of resistance to these antimicro-
bial agents have been reported by Soriano et al. (28), who
studied 11 strains of C. striatum; these authors also found that
all 11 strains were susceptible to doxycycline and fusidic acid
and resistant to nitrofurantoin; most of them were oxacillin
resistant. MICs of gentamicin for these 11 strains ranged from
0.03 to 4 mg/ml (MIC at which 90% of the isolates are inhib-
ited, 2 mg/ml); for our isolates, however, only 45% of strains
were susceptible (as determined by disk for diffusion) to this
drug although 87% were susceptible to amikacin, which sug-
gests different activities of the two aminoglycosides. Although
ciprofloxacin is not active against most C. striatum strains (this
report and references 22 and 28), previous results (22) indicate
that newer fluoroquinolones (i.e., clinafloxacin) are highly ac-
tive against the organism. This pattern of susceptibility is dif-
ferent from that of C. jeikeium and C. urealyticum, which are
commonly multiresistant organisms (28). Resistance to clinda-
mycin, erythromycin, and tetracycline has also been reported
for other coryneform bacteria (28) but was not noted in a
recent report on C. diphtheriae isolated from northwestern
Russia (20).
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